SCHEMBL3655510

SCHEMBL3655510

C=C[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.68
GPBAR1 Q8TDU6 3/20 0.68
CYP3A4 P08684 3/20 0.68
CYP1A2 P05177 2/20 0.68
CYP2C9 P11712 2/20 0.68
CYP2C19 P33261 2/20 0.68
SHBG P04278 1/20 0.68
SERPINA6 P08185 1/20 0.68
TSHR P16473 1/20 0.68
HSD17B10 Q99714 1/20 0.68
GABRP O00591 2/20 0.60
GABRD O14764 2/20 0.60
G6PD P11413 2/20 0.60
GABRA1 P14867 2/20 0.60
GABRB1 P18505 2/20 0.60
GABRG2 P18507 2/20 0.60
GABRB3 P28472 2/20 0.60
GABRA5 P31644 2/20 0.60
GABRA3 P34903 2/20 0.60
GABRA2 P47869 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13917761 1.00 LMNA (0.68) LMNAGPBAR1CYP3A4CYP1A2CYP2C9
SCHEMBL3652170 1.00 LMNA (0.68) LMNAGPBAR1CYP3A4CYP1A2CYP2C9
SCHEMBL3651739 1.00 LMNA (0.68) LMNAGPBAR1CYP3A4CYP1A2CYP2C9
SCHEMBL3654366 1.00 LMNA (0.68) LMNAGPBAR1CYP3A4CYP1A2CYP2C9
SCHEMBL3651742 1.00 LMNA (0.68) LMNAGPBAR1CYP3A4CYP1A2CYP2C9
SCHEMBL18476800 0.89 LMNA (0.60) LMNAGPBAR1CYP3A4CYP1A2CYP2C9
SCHEMBL25354429 0.86 GABRA1 (0.68) LMNAGPBAR1CYP3A4CYP1A2CYP2C9
SCHEMBL1591682 0.86 LMNA (0.68) LMNAGPBAR1CYP3A4CYP1A2CYP2C9
SCHEMBL8412854 0.86 GABRA1 (0.68) LMNAGPBAR1CYP3A4CYP1A2CYP2C9
SCHEMBL3630957 0.86 LMNA (0.68) LMNAGPBAR1CYP3A4CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140045805-A1 Fragrance Compositions and Other Compositions Which Contain Naturally Occurring Substances Found in Corals HUMAN PHEROMONE SCIENCES, INC. (US) 2014-02-13 US disclosed
EP-2194962-A2 FRAGRANCE COMPOSITIONS AND OTHER COMPOSITIONS WHICH CONTAIN NATURALLY OCCURRING SUBSTANCES FOUND IN CORALS Human Pheromone Sciences, Inc. (US) 2010-06-16 EP disclosed
WO-2009039103-A2 FRAGRANCE COMPOSITIONS AND OTHER COMPOSITIONS WHICH CONTAIN NATURALLY OCCURRING SUBSTANCES FOUND IN CORALS HUMAN PHEROMONE SCIENCES, INC. (US) 2009-03-26 WO disclosed
US-20090075964-A1 FRAGRANCE COMPOSITIONS AND OTHER COMPOSITIONS WHICH CONTAIN NATURALLY OCCURRING SUBSTANCES FOUND IN CORALS HUMAN PHEROMONE SCIENCES, INC. (US) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090075964-A1 FRAGRANCE COMPOSITIONS AND OTHER COMPOSITIONS WHICH CONTAIN NATURALLY OCCURRING SUBSTANCES FOUND IN CORALS NR5A1, MC5R, CYP17A1 LMNA 3317/4885GPBAR1 2493/4885CYP3A4 1421/4885
US-20140045805-A1 Fragrance Compositions and Other Compositions Which Contain Naturally Occurring Substances Found in Corals NR5A1, MC5R, CYP17A1 LMNA 3317/4885GPBAR1 2493/4885CYP3A4 1421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.